Medtronic plc (NYSE: MDT) shares are trading at USD 94.79 as of the latest session, reflecting a slight decline of 0.45 points or -0.47%. The company remains a major player in the medical devices industry, with a global reach and a market capitalization exceeding USD 121.58 billion. This update reviews the current stock performance, market context, and key corporate profile details.
Company Overview
Founded in 1949 and headquartered in Dublin, Ireland, Medtronic plc develops, manufactures, and sells device-based medical therapies worldwide. The company operates across four major portfolios: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes Operating Unit. Products include pacemakers, defibrillators, cardiac monitoring systems, cardiovascular intervention tools, surgical and robotic devices, neurological instruments, and diabetes management systems.
Its client base includes healthcare systems, physicians, and patients. Medtronic’s role in improving medical technology places it at the center of innovation in the healthcare sector.
Stock Performance
Medtronic’s current trading price of USD 94.79 falls near the upper limit of its 52-week range (USD 79.29 – USD 96.25). The decline of -0.45 points today represents a minor fluctuation, common in large-cap stocks. Trading volume in the latest session was 7.53 million shares, slightly below the average daily volume of 8.49 million.
For investors, this reflects steady market interest, with price movements staying within a predictable band. Dividend yield is supported by an annualized payout of USD 2.82 per share, appealing to income-focused shareholders.
Market Position and Sector
Medtronic operates in the “Medical – Devices” industry within the healthcare sector. The company’s large market capitalization of USD 121.58 billion positions it among the leading global device manufacturers. Its diversified product offering within cardiovascular, surgical, and neurological care gives it resilience against sector-specific downturns.
The healthcare sector generally benefits from long-term demand stability, driven by population aging and advances in treatment technology. Medtronic’s extensive portfolio and international footprint add to its competitive edge.
Governance and Leadership
Geoffrey Straub Martha serves as Chief Executive Officer, overseeing a workforce of approximately 95,000 full-time employees. Under his leadership, the company continues to innovate and expand into new medical therapy areas.
Leadership in a regulated field such as medical devices requires a strong compliance culture and strategic foresight. Medtronic’s governance framework aims to align operational goals with stakeholder interests while meeting healthcare industry regulations.
Key Financial Data
- Price: USD 94.79 per share
- Market Cap: USD 121.58 billion
- Annual Dividend: USD 2.82 per share
- 52-Week Range: USD 79.29 – USD 96.25
- Daily Change: -0.45 (-0.47%)
- Volume: 7,535,662 shares
- Average Volume: 8,491,358 shares
- Exchange: New York Stock Exchange (NYSE)
- ISIN: IE00BTN1Y115
- CUSIP: G5960L103
- CIK: 0001613103
These metrics provide insight into liquidity, income potential, and valuation levels, which are key to assessing investment suitability.
FAQ
- What is Medtronic’s annual dividend? USD 2.82 per share, paid on a regular schedule.
- Where is Medtronic headquartered? Dublin, Ireland, with an address at 20 On Hatch, Galway.
- On which exchange is MDT traded? It is listed on the New York Stock Exchange (NYSE).
- How many employees does Medtronic have? Approximately 95,000 full-time employees globally.
- What sector and industry does it belong to? Healthcare sector, Medical – Devices industry.
Conclusion
Medtronic plc maintains a strong market presence within the medical devices industry. Current stock levels suggest stability with modest daily movements. For stakeholders, the combination of solid dividend yield, extensive product lines, and robust market cap supports confidence in long-term positioning.
Disclaimer
This article is for informational purposes only. It does not constitute financial advice. Investors should conduct their own research before making investment decisions.
Announcement
For full information about the company, see the link below.
https://www.medtronic.com